SEMPRINI, MARIA SOFIA
 Distribuzione geografica
Continente #
EU - Europa 98
NA - Nord America 52
AS - Asia 18
AF - Africa 3
Totale 171
Nazione #
IT - Italia 69
US - Stati Uniti d'America 52
SG - Singapore 9
CH - Svizzera 7
DE - Germania 5
IE - Irlanda 5
HK - Hong Kong 4
AT - Austria 3
CI - Costa d'Avorio 2
CN - Cina 2
FI - Finlandia 2
NL - Olanda 2
PK - Pakistan 2
SE - Svezia 2
BG - Bulgaria 1
EE - Estonia 1
GB - Regno Unito 1
JO - Giordania 1
TG - Togo 1
Totale 171
Città #
Bologna 19
Milan 8
Bern 7
Houston 7
Singapore 7
New York 6
Bo 5
Dublin 5
Vicenza 5
Ashburn 4
Council Bluffs 4
Hong Kong 4
Los Angeles 4
Parma 3
Vienna 3
Abidjan 2
Amsterdam 2
Boydton 2
Castenaso 2
Cento 2
Chandler 2
Porto Recanati 2
Rimini 2
San Benedetto del Tronto 2
Turin 2
Amman 1
Beijing 1
Bremen 1
Correggio 1
Costa Volpino 1
Helsinki 1
Hounslow 1
Islamabad 1
Lappeenranta 1
Lomé 1
Montescudo 1
Mülheim 1
Peshawar 1
Reggio Emilia 1
Shanghai 1
Sofia 1
Tallinn 1
Toenisvorst 1
Totale 129
Nome #
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 76
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 55
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 48
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 12
Totale 191
Categoria #
all - tutte 723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202376 0 0 0 7 13 12 10 2 9 2 8 13
2023/202487 5 1 21 11 16 9 6 7 0 6 1 4
2024/202528 6 22 0 0 0 0 0 0 0 0 0 0
Totale 191